APLM vs BIIB: Which Stock is Better?
Side-by-side comparison of Apollomics Inc and Biogen Inc in 2026
APLM
Apollomics Inc
$14.27
BIIB
Biogen Inc
$180.54
Key Metrics Comparison
| Metric | APLM | BIIB | Winner |
|---|---|---|---|
| Market Cap | $32.64M | $26.26B | BIIB |
| P/E Ratio | N/A | 20.38 | BIIB |
| EPS (TTM) | $N/A | $8.78 | BIIB |
| Revenue Growth | 3.8% | -0.1% | APLM |
| Gross Margin | 100.0% | 78.9% | APLM |
Analyze APLM
Full quant analysis
Analyze BIIB
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is APLM or BIIB a better investment?
Comparing APLM and BIIB: Apollomics Inc has a market cap of $32.64M while Biogen Inc has $26.26B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between APLM and BIIB?
APLM (Apollomics Inc) and BIIB (Biogen Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: APLM or BIIB?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: APLM or BIIB?
APLM has higher revenue growth at 3.8% vs -0.1% for BIIB.
Which company is more profitable: APLM or BIIB?
Apollomics Inc (APLM) has higher gross margins at 100.0% compared to 78.9% for BIIB.
Which is the larger company: APLM or BIIB?
Biogen Inc (BIIB) is larger with a market cap of $26.26B compared to $32.64M for APLM.
Should I buy APLM or BIIB in 2026?
Both APLM and BIIB have investment merit. APLM trades at $14.27 while BIIB trades at $180.54. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between APLM and BIIB stock?
Key differences: Market Cap ($32.64M vs $26.26B), P/E Ratio (N/A vs 20.4x), Revenue Growth (3.8% vs -0.1%), Gross Margin (100.0% vs 78.9%).